A detailed history of Financial Management Professionals, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 4,991 shares of ABBV stock, worth $969,252. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,991
Previous 4,249 17.46%
Holding current value
$969,252
Previous $774,000 10.59%
% of portfolio
0.12%
Previous 0.11%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $114,854 - $134,123
742 Added 17.46%
4,991 $856,000
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $139,842 - $159,337
-875 Reduced 17.08%
4,249 $774,000
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $53,251 - $59,973
387 Added 8.17%
5,124 $794,000
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $63,856 - $73,922
478 Added 11.22%
4,737 $706,000
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $80,566 - $100,259
608 Added 16.65%
4,259 $574,000
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $47,721 - $54,958
330 Added 9.94%
3,651 $582,000
Q4 2022

Jan 11, 2023

BUY
$138.31 - $165.87 $34,577 - $41,467
250 Added 8.14%
3,321 $537,000
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $122,936 - $140,999
-916 Reduced 22.97%
3,071 $412,000
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $69,773 - $88,704
-507 Reduced 11.28%
3,987 $611,000
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $29,563 - $36,680
224 Added 5.25%
4,494 $728,000
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $966 - $1,223
9 Added 0.21%
4,270 $578,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $31,175 - $35,388
293 Added 7.38%
4,261 $460,000
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $23,356 - $26,020
222 Added 5.93%
3,968 $447,000
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $44,398 - $48,877
434 Added 13.1%
3,746 $405,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $12,475 - $16,843
155 Added 4.91%
3,312 $355,000
Q3 2020

Oct 26, 2020

BUY
$85.91 - $100.83 $6,872 - $8,066
80 Added 2.6%
3,157 $277,000
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $175,574 - $234,944
2,393 Added 349.85%
3,077 $302,000
Q1 2020

Apr 24, 2020

SELL
$64.5 - $97.79 $3,225 - $4,889
-50 Reduced 6.81%
684 $52,000
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $5,698 - $7,129
79 Added 12.06%
734 $65,000
Q2 2018

Aug 01, 2018

SELL
$89.78 - $106.23 $3,950 - $4,674
-44 Reduced 6.29%
655 $61,000
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $64,314 - $86,123
699 New
699 $66,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $343B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.